Head and Neck Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a confirmed invasive squamous cell carcinoma (a type of cancer) in the head and neck area, specifically in locations including the sinonasal area, oral cavity, hypopharynx, larynx, HPV-negative oropharyngeal region, or advanced HPV-positive oropharyngeal region (T4 stage, any lymph node involvement)
- People who are planned to receive standard curative radiation therapy, with or without chemotherapy (cisplatin or cetuximab) and/or a medication called nimorazole
- People aged 18 years or older
- People with a general health and activity level rated 0–2 on the WHO performance scale, meaning they are able to carry out at least some daily activities independently (confirm with trial site)
- People who have signed a consent form agreeing to take part in the trial
- People who are able to understand information about the study and complete questionnaires
Who may not be able to join:
- People whose cancer is at an early stage classified as cT1 cN0-N1 cM0 (confirm with trial site for exact staging definitions)
- People with early-stage glottic (voice box) cancer classified as cT1–T2 cN0 cM0
- People with HPV-positive oropharyngeal cancer at stages T1–T3 (regardless of lymph node involvement)
- People who have diabetes mellitus
- People who are currently taking blood-thinning (anticoagulant) medications
- People who are currently smoking and/or have active alcohol misuse
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Einar Dale, Oslo University Hospital
Phone: +4722934000
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Late mucosal ulcer
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.